{"url_path":"/sec/phge/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-059587-index.html","accession_number":"0001213900-26-059587","cik":"0001739174","ticker":"PHGE","issuer_name":"BiomX Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-059587-index.html","primary_entity_key":"0001739174","primary_entity_name":"BiomX Inc."},"word_count":425,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 10-Q**\n\n \n\n**(Mark One)**\n\n☒ **QUARTERLY REPORT PURSUANT TO SECTION\n13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the quarter ended March 31, 2026**\n\n \n\n☐ **TRANSITION REPORT PURSUANT TO SECTION\n13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the transition period from                    to                  **\n\n \n\n**Commission file number: 001-38762**\n\n \n\n**BiomX Inc.**\n\n(Exact Name of Registrant as Specified in Its\nCharter) \n\n \n\n**Delaware**   **82-3364020**\n\n(State or other jurisdiction of\nincorporation or organization)    (I.R.S. Employer\nIdentification No.) \n\n \n\n**850 New Burton Road, Suite 201, Dover, DE **   **19904**\n\n(Address of principal executive offices)   (Zip Code)\n\n \n\nRegistrant’s telephone number, including\narea code: **+972 52 437 4900**\n\n \n\nSecurities registered pursuant to Section 12(b)\nof the Act: \n\n \n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange on which registered**\n\nCommon stock, $0.0001 par value   PHGE   NYSE American\n\n \n\nIndicate by check mark whether the registrant\n(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12\nmonths (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements\nfor the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nhas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405\nof this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes\n☒ No ☐\n\n \n\nIndicate by check mark whether the registrant\nis a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.\nSee the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”\nand “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐\n\nNon-accelerated filer ☒ Smaller reporting company ☒\n\n  Emerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting\nstandards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant\nis a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nThe number of shares outstanding of the Registrant’s shares\nof Common Stock as of May 20, 2026 was 10,146,516.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**BIOMX, INC.**\n\n \n\n**Form 10-Q**\n\n \n\n**March 31, 2026**\n\n** **\n\n   \n**Page**\n\n \n \n\n**PART I — FINANCIAL\nINFORMATION**"}